Publications
Filters: Keyword is Plasmodium vivax [Clear All Filters]
“Declining Burden of Plasmodium vivax in a Population in Northwestern Thailand from 1995 to 2016 before Comprehensive Primaquine Prescription for Radical Cure”, Am J Trop Med Hyg, vol. 102, no. 1, pp. 147-150, 2020.
, “G6PD deficiency in malaria endemic areas of Nepal”, Malar J, vol. 19, no. 1, p. 287, 2020.
, “Optimizing G6PD testing for Plasmodium vivax case management: why sex, counseling, and community engagement matter”, Wellcome Open Res, vol. 5, p. 21, 2020.
, “Vivax malaria in pregnancy and lactation: a long way to health equity”, Malar J, vol. 19, no. 1, p. 40, 2020.
, “Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria”, Clin Infect Dis, vol. 68, no. 8, pp. 1311-1319, 2019.
, “Contribution of Asymptomatic Plasmodium Infections to the Transmission of Malaria in Kayin State, Myanmar”, J Infect Dis, vol. 219, no. 9, pp. 1499-1509, 2019.
, “The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis”, BMC Med, vol. 17, no. 1, p. 151, 2019.
, “Hepatic spheroids used as an in vitro model to study malaria relapse”, Biomaterials, vol. 216, p. 119221, 2019.
, “The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis”, Wellcome Open Res, vol. 4, p. 25, 2019.
, “Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression”, Eur J Haematol, vol. 100, no. 3, pp. 294-303, 2018.
, “Plasmodium vivax Merozoite Surface Protein 1 Paralog as a Mediator of Parasite Adherence to Reticulocytes”, Infect Immun, vol. 86, no. 9, 2018.
, “Primaquine-induced haemolysis in females heterozygous for G6PD deficiency”, Malar J, vol. 17, no. 1, p. 101, 2018.
, “Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice”, Med Microbiol Immunol, vol. 207, no. 5-6, pp. 271-286, 2018.
, “Asian G6PD-Mahidol reticulocytes sustain normal Plasmodium vivax development”, J Infect Dis, 2017.
, “Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection”, Mol Immunol, vol. 90, pp. 158-171, 2017.
, “Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression”, Eur J Haematol, 2017.
, “Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP119”, Vaccine, vol. 35, no. 18, pp. 2463-2472, 2017.
, “Plasmodium vivax genetic diversity and heterozygosity in blood samples and resulting oocysts at the Thai-Myanmar border”, Malar J, vol. 16, no. 1, p. 355, 2017.
, “Plasmodium vivax rhomboid-like protease 1 gene diversity in Thailand”, Exp Parasitol, vol. 181, pp. 1-6, 2017.
, , “A Basis for Rapid Clearance of Circulating Ring-Stage Malaria Parasites by the Spiroindolone KAE609”, J Infect Dis, vol. 213, no. 1, pp. 100-4, 2016.
, “Management of relapsing Plasmodium vivax malaria”, Expert Rev Anti Infect Ther, 2016.
, “Microgeographically diverse Plasmodium vivax populations at the Thai-Myanmar border”, Infect Genet Evol, vol. 45, pp. 341-346, 2016.
, “Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast”, Infect Immun, vol. 82, no. 3, pp. 1296-1307, 2014.
, “Small molecule targeting malaria merozoite surface protein-1 (MSP-1) prevents host invasion of divergent plasmodial species”, J Infect Dis, vol. 210, no. 10, pp. 1616-26, 2014.
,